NEW YORK — Consumer genomics services firm DescendantsDNA said Thursday that it has signed on the Broad Institute's Broad Clinical Labs to provide it with whole-genome sequencing and related services.

纽约-消费者基因组学服务公司DescendantsDNA周四表示，它已经与Broad Institute的Broad Clinical Labs签约，为其提供全基因组测序和相关服务。

DescendantsDNA provides its members with DNA self-test kits and healthcare reports based on their genetic profiles. Under an existing agreement, Houston-based DescendantsDNA uses Fabric Genomics' Fabric Enterprise software to help analyze customers' genomic data and generate the reports.

后代DNA为其成员提供基于其遗传特征的DNA自检试剂盒和医疗保健报告。根据现有协议，位于休斯顿的后代DNA使用Fabric Genomics的Fabric Enterprise软件来帮助分析客户的基因组数据并生成报告。

Financial and other terms of the deal with Broad Clinical Labs were not disclosed.

与Broad Clinical Labs交易的财务和其他条款未披露。

'Our proprietary reports offer personalized recommendations, aligning each member's DNA with the most effective therapies and providing comprehensive genetic, pharmacogenomic, and nutritional counseling,' DescendantsDNA Founder, Chairman, and CEO Rod Cutsinger said in a statement.

“我们的专有报告提供了个性化的建议，将每个成员的DNA与最有效的疗法相结合，并提供全面的遗传，药物基因组学和营养咨询，”DegenantsDNA创始人，董事长兼首席执行官罗德·卡特辛格（RodCutsinger）在一份声明中说。